Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Muzi

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample SizeBrenda F Kurland, Mark Muzi, Lanell M Peterson, et al.
Cancer Research|April 16, 2009
Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomasMindy D Szeto, Gargi Chakraborty, Jennifer Hadley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primateSara Eyal, Francisco S Chung, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSFRobert K Doot, Lisa K Dunnwald, Erin K Schubert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2021
Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
Tomography (Ann Arbor, Mich.)|January 26, 2016
Effect of <sup>18</sup>F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancerKristen A Wangerin, Mark Muzi, Lanell M Peterson, et al.
Molecular Imaging|August 19, 2003
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient resultsJoanne M Wells, David A Mankoff, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomasKristin R Swanson, Gargi Chakraborty, Christina H Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference RegionsMark Muzi, Lanell M Peterson, Janet N O'Sullivan, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample SizeBrenda F Kurland, Mark Muzi, Lanell M Peterson, et al.
Cancer Research|April 16, 2009
Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomasMindy D Szeto, Gargi Chakraborty, Jennifer Hadley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primateSara Eyal, Francisco S Chung, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSFRobert K Doot, Lisa K Dunnwald, Erin K Schubert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2021
Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
Tomography (Ann Arbor, Mich.)|January 26, 2016
Effect of <sup>18</sup>F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancerKristen A Wangerin, Mark Muzi, Lanell M Peterson, et al.
Molecular Imaging|August 19, 2003
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient resultsJoanne M Wells, David A Mankoff, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomasKristin R Swanson, Gargi Chakraborty, Christina H Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference RegionsMark Muzi, Lanell M Peterson, Janet N O'Sullivan, et al.
Pageof 9